Select Medical Holdings (SEM)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	243,491	224,726	203,712	180,682	158,994	181,347	231,109	340,796	402,225	429,642	429,660	316,416	258,995	213,788	167,574	160,740	148,449	141,055	143,240	144,935
Total stockholders’ equity	US$ in thousands	1,288,300	1,267,810	1,246,040	1,170,450	1,121,920	1,105,600	1,071,410	1,138,140	1,109,980	1,145,500	1,234,220	1,145,980	1,060,480	1,038,590	992,883	808,638	770,972	754,718	846,009	802,031
ROE		18.90%	17.73%	16.35%	15.44%	14.17%	16.40%	21.57%	29.94%	36.24%	37.51%	34.81%	27.61%	24.42%	20.58%	16.88%	19.88%	19.25%	18.69%	16.93%	18.07%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $243,491K ÷ $1,288,300K
= 18.90%

Select Medical Holdings Corporation's return on equity (ROE) has displayed a varying trend over the last eight quarters. The ROE has been relatively stable in the range of 13.67% to 18.22%, with a notable peak of 28.94% in Q1 2022. However, there was a decline in ROE from Q2 2022 to Q4 2023. This indicates that the company's ability to generate profits from shareholder equity has fluctuated over time. It is essential for stakeholders to monitor the trend in ROE to assess the company's efficiency in utilizing shareholder funds to generate returns.

Peer comparison

Dec 31, 2023

Company name

Symbol

ROE

Select Medical Holdings

SEM

18.90%

Encompass Health Corp